Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Japan flag Japan · Delayed Price · Currency is JPY
5,833.00
-9.00 (-0.15%)
Apr 22, 2026, 3:30 PM JST
Market Cap434.29B +0.4%
Revenue (ttm)165.74B +0.1%
Net Income3.66B -63.7%
EPS49.18 -63.7%
Shares Out74.34M
PE Ratio118.79
Forward PE40.87
Dividend106.00 (1.80%)
Ex-Dividend DateJun 29, 2026
Volume129,900
Average Volume186,765
Open5,842.00
Previous Close5,842.00
Day's Range5,801.00 - 5,871.00
52-Week Range4,850.00 - 6,140.00
Beta0.26
RSI47.55
Earnings DateMay 8, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sh... [Read more]

Founded 1886
Employees 3,731
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Financial Statements